Australia E-Cigarette Market, By Product Type (Disposable, Rechargeable, Modular), By Flavor (Tobacco, Non-Tobacco), By Sales Channel (Specialty Stores, Tobacconist, Online, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 566.49 Million
CAGR (2026-2031)	7.26%
Fastest Growing Segment	Disposable
Largest Market	ACT and New South Wales
Market Size (2031)	USD 862.62 Million

Market Overview

The Australia E-Cigarette Market will grow from USD 566.49 Million in 2025 to USD 862.62 Million by 2031 at a 7.26% CAGR. E-cigarettes, commonly known as vapes, are electronic devices that heat a liquid solution to generate an aerosol for inhalation, simulating the act of smoking without combustion. The Australia e-cigarette market's growth is primarily driven by a discernible shift in consumer preferences away from conventional tobacco products towards perceived harm-reduced alternatives, coupled with increasing public health awareness and a demand for smoking cessation aids.

However, the market faces a significant impediment in its complex and rapidly evolving regulatory landscape, which includes bans on disposable vape imports and the mandated transition to pharmacy-only sales for therapeutic products, leading to considerable industry uncertainty. This stringent regulation has also contributed to a thriving illicit market; according to the Australian Association of Convenience Stores (AACS) citing the National Drug and Alcohol Wastewater survey, in the period between August 2024 and August 2025, national nicotine consumption increased by 4 per cent, reaching historic highs.

Key Market Drivers

Growing demand for vaping as a cessation aid and emerging efficacy evidence
Growing consumer demand for smoking alternatives and the perception of e-cigarettes as a smoking cessation tool significantly influence the Australian e-cigarette market. Many individuals are actively seeking ways to reduce or quit traditional tobacco use, turning to vaping products as a perceived less harmful option. This inclination is supported by emerging evidence regarding cessation efficacy. For instance, according to an article titled 'Vaping can help disadvantaged Australians quit smoking. What now for clinical practice?', published in February 2026, participants in a vaping group were three times more likely to achieve continuous abstinence from smoking, with a 28.4 percent success rate, compared to a nicotine replacement therapy group at 9.6 percent. This indicates a tangible benefit for some seeking to transition away from combustible cigarettes.

Illicit market scale and its effect on the nicotine supply
Compounding this dynamic is the pervasive role of the illicit market in product availability, driven largely by stringent regulatory hurdles for legitimate products. The presence of an unregulated supply chain ensures a continuous, albeit illegal, flow of e-cigarettes into the country, circumventing legal restrictions on sales and imports. This illicit activity is substantial; the Australian Border Force (ABF) detected, seized, and destroyed more than six million illicit vaping products before they could be sold illegally between July 1, 2024, and June 30, 2025. The sheer volume of these seizures highlights the scale of the underground market’s operations. This illicit supply significantly impacts the overall nicotine landscape, as evidenced by data from the Australian Bureau of Statistics which reported that about 80 percent of cigarettes, vapes, and other nicotine products consumed in 2025 originated from illegal sources.

Download Free Sample Report

Key Market Challenges

Regulatory Uncertainty and Its Impact on Growth
The complex and rapidly evolving regulatory landscape presents a significant challenge to the growth of the Australia e-cigarette market. Frequent changes in regulations, including import bans on disposable vapes and the mandated shift to pharmacy-only sales for therapeutic products, create substantial uncertainty for legitimate businesses. This environment complicates operational planning, product development, and supply chain management for compliant market participants.

Illicit Trade Undermines the Regulated Market
The stringent regulatory framework has inadvertently fostered a robust illicit market, directly undermining the growth of the legal sector. As legitimate channels become more restricted and costly, consumers are increasingly diverted to unregulated sources where products are often cheaper and more accessible. According to the Australian Association of Convenience Stores (AACS), in the period between July 2024 and June 2025, more than six million illicit vaping products were detected, seized, and destroyed by the Australian Border Force. This widespread availability of unauthorized products diminishes potential revenue for licensed businesses and distorts market competition, effectively hampering the expansion of the regulated e-cigarette market.

Key Market Trends

Regulatory Shift to Pharmacy-Only Therapeutic Vaping Sales
The Australia E-Cigarette Market is significantly shaped by the ongoing adaptation to a pharmacy-only sales model for therapeutic vaping products. This regulatory shift fundamentally alters distribution, directing legal sales through healthcare channels and aiming for stricter control over product accessibility. Despite initial challenges, the market is gradually adjusting. According to the Australian Government Drugs Authority (TGA), June 2026, in the 'Notified vape list: goods for smoking cessation or nicotine dependence', over 2,200 pharmacies supplied more than 220,000 therapeutic vaping goods in 2025. This demonstrates a measurable establishment of the legitimate supply chain through pharmaceutical outlets, integrating products within a medically supervised context.

Declining Youth Vaping and Evolving Social Perceptions
Another prominent trend impacting the Australian e-cigarette market is the decreasing youth vaping rates and evolving social perceptions among young people. Public health campaigns and stricter enforcement reshape attitudes, reducing engagement among adolescent demographics. This shift in social acceptability and access is crucial for long-term market dynamics. According to the Cancer Council and the University of Sydney, July 2025, in their 'Generation Vape study', the rate of vaping among 14-17-year-olds in Australia decreased from 18 percent in early 2023 to 15 percent in 2025. This decline suggests efforts to deter youth vaping are yielding positive outcomes, potentially leading to a smaller future consumer base from this age group.

Segmental Insights

Drivers of rapid growth in the Australian disposable e-cigarette segment
The disposable segment is currently the fastest growing within the Australia E-Cigarette Market, primarily driven by its significant uptake and widespread availability. This rapid expansion stems from the inherent convenience and ease of use these devices offer, as they require no maintenance or refilling, along with their low initial cost. Despite stringent regulations by the Australian government and the Therapeutic Goods Administration, including a ban on disposable vape importation, a robust illicit market ensures their accessibility. The strong consumer demand for diverse flavors and the high nicotine potency of modern disposables further contribute to their swift adoption, particularly among younger demographics seeking readily available options.

Regional Insights

ACT and NSW: Regional leadership, urban demand, and regulatory dynamics
The Australian Capital Territory and New South Wales are pivotal regions leading the national e-cigarette market. This dominance is primarily driven by their substantial urban populations and elevated consumer awareness regarding alternative smoking products. Sydney, as a significant metropolitan hub, fuels demand from both individuals transitioning from traditional smoking and health-conscious younger demographics. The market's growth in these regions is influenced by the dual availability of vape products through regulated pharmacy channels, overseen by the Therapeutic Goods Administration, alongside a notable illicit market that caters to consumer preferences.

Recent Developments

• In July 2025, companies manufacturing therapeutic vaping products for the Australian e-cigarette market were mandated to comply with strengthened safety and quality standards introduced by the Therapeutic Goods Administration. These revised standards, which were initially published in October 2024, established more rigorous requirements for product ingredients, packaging, and labeling. Manufacturers whose products did not meet these enhanced specifications faced their removal from the official notified vape list, thereby compelling them to either modify existing therapeutic products or introduce new, compliant offerings for distribution through licensed pharmacies in Australia.
• In October 2024, the accessibility framework for certain therapeutic vapes within the Australian e-cigarette market was modified. Adults aged 18 and over became eligible to purchase therapeutic vapes with a nicotine concentration of 20 mg/mL or less from participating pharmacies without requiring a prior prescription, following a pharmacist's clinical assessment. This policy adjustment necessitated that companies ensure their low-nicotine therapeutic vape products were readily available and compliant for over-the-counter sale in pharmacies, adapting their supply strategies to align with these new purchasing pathways.
• In July 2024, the Australian e-cigarette market experienced a significant structural change as the domestic manufacturing, supply, and commercial possession of non-therapeutic and disposable single-use vapes became unlawful. This regulatory action required companies to cease these activities, with only established pharmaceutical supply chains authorized to distribute vapes intended for smoking cessation or nicotine dependence. Consequently, businesses within the Australian e-cigarette sector had to adjust their operational and distribution models, focusing on making their compliant therapeutic products accessible exclusively through the pharmacy channel.
• Throughout 2024, companies engaged in the Australian e-cigarette market adapted their product portfolios in response to new regulations concerning flavor profiles for therapeutic vapes. The Therapeutic Goods Administration restricted the permissible flavors for these products, when supplied via pharmacies, to only mint, menthol, or tobacco. This regulatory directive required manufacturers to either reformulate existing therapeutic product lines or develop new ones that exclusively adhered to these limited flavor options, thereby concentrating product development efforts within these specific categories for the Australian market.

Key Market Players

• British American Tobacco plc
• Philip Morris International Inc.
• Japan Tobacco Inc.
• Imperial Brands plc
• RELX Technology
• NJOY Holdings Inc.
• Vaporesso
• SMOK
• JUUL Labs Inc.
• GeekVape Technology Co. Ltd.

By Product Type	By Flavor	By Sales Channel	By Region
Disposable Rechargeable Modular	Tobacco Non-Tobacco	Specialty Stores Tobacconist Online Others	Australia Capital Territory & New South Wales Northern Territory & Southern Australia Western Australia Queensland Victoria & Tasmania

Report Scope:

In this report, the Australia E-Cigarette Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Australia E-Cigarette Market, By Product Type:

• Disposable
• Rechargeable
• Modular

• Australia E-Cigarette Market, By Flavor:

• Tobacco
• Non-Tobacco

• Australia E-Cigarette Market, By Sales Channel:

• Specialty Stores
• Tobacconist
• Online
• Others

• Australia E-Cigarette Market, By Region:

• Australia Capital Territory & New South Wales
• Northern Territory & Southern Australia
• Western Australia
• Queensland
• Victoria & Tasmania